Role of serum albumin as a nanoparticulate carrier for nose ‐to‐brain delivery of R‐flurbiprofen: implications for the treatment of Alzheimer's disease

ConclusionsSerum albumin‐based nanoparticles administered via the nasal route may be a viable approach in delivering therapeutic agents to the brain to alleviate mitochondrial dysfunction in AD.

Source: Journal of Pharmacy and Pharmacology - October 16, 2017 Category: Drugs & Pharmacology Authors: Ling Rong Wong, Paul C. Ho Tags: Research Paper Source Type: research